A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase Cζ (PKCζ) and PKC-related kinase 2 by PDK1

被引:155
|
作者
Balendran, A
Biondi, RM
Cheung, PCF
Casamayor, A
Deak, M
Alessi, DR
机构
[1] Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland
[2] Univ Dundee, Div Signal Transduct Therapy, Dundee DD1 5EH, Scotland
关键词
D O I
10.1074/jbc.M000421200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the AGC subfamily of protein kinases including protein kinase B, p70 S6 kinase, and protein kinase C (PKC) isoforms are activated and/or stabilized by phosphorylation of two residues, one that resides in the T-loop of the kinase domain and the other that is located C-terminal to the kinase domain in a region known as the hydrophobic motif. Atypical PKC isoforms, such as PKC zeta, and the PKC-related kinases, like PRK2, are also activated by phosphorylation of their T-loop site but, instead of possessing a phosphorylatable Ser/Thr in their hydrophobic motif, contain an acidic residue. The 3-phosphoinositide-dependent protein kinase (PDK1) activates many members of the AGC subfamily of kinases in vitro, including PKC zeta and PRK2 by phosphorylating the T-loop residue. In the present study we demonstrate that the hydrophobic motifs of PKC zeta and PKC iota, as well as PRK1 and PRK2, interact with the kinase domain of PDK1. Mutation of the conserved residues of the hydrophobic motif of full-length PKC zeta, fulllength PRK2, or PRK2 lacking its N-terminal regulatory domain abolishes or significantly reduces the ability of these kinases to interact with PDK1 and to become phosphorylated at their T-loop sites in rtiao. Furthermore, overexpression of the hydrophobic motif of PRK2 in cells prevents the T-loop phosphorylation and thus inhibits the activation of PRK2 and PKC zeta. These findings indicate that the hydrophobic motif of PRK2 and PKC zeta acts as a "docking site" enabling the recruitment of PDK1 to these substrates. This is essential for their phosphorylation by PDK1 in cells.
引用
收藏
页码:20806 / 20813
页数:8
相关论文
共 50 条
  • [11] Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2
    Kobayashi, Takayasu
    Cohen, Philip
    Biochemical Journal, 1999, 339 (pt 2): : 319 - 328
  • [12] Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2
    Kobayashi, T
    Cohen, P
    BIOCHEMICAL JOURNAL, 1999, 339 : 319 - 328
  • [13] Autophagy and 3-Phosphoinositide-Dependent Kinase 1 (PDK1)-Related Kinome in Pagetic Osteoclasts
    McManus, Stephen
    Bisson, Martine
    Chamberland, Richard
    Roy, Michele
    Nazari, Shekeba
    Roux, Sophie
    JOURNAL OF BONE AND MINERAL RESEARCH, 2016, 31 (07) : 1334 - 1343
  • [14] Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1
    Le Good, JA
    Ziegler, WH
    Parekh, DB
    Alessi, DR
    Cohen, P
    Parker, PJ
    SCIENCE, 1998, 281 (5385) : 2042 - 2045
  • [15] Role of phosphoinositide-dependent protein kinase-1 (PDK1) in leukemogenesis of acute leukemia
    Kampa, Kerstin M.
    Kopp, Hans Georg
    Schittenhelm, Marcus M.
    CANCER RESEARCH, 2012, 72
  • [16] 3-Phosphoinositide-Dependent Protein Kinase 1 (Pdk1) Regulates Macrophage Migration, Polarization, and Insulin Sensitivity
    Kawano, Yoshinaga
    Nakae, Jun
    Itoh, Hiroshi
    DIABETES, 2012, 61 : A85 - A85
  • [17] p21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDK1)
    King, CC
    Gardiner, EMM
    Zenke, FT
    Bohl, BP
    Newton, AC
    Hemmings, BA
    Bokoch, GM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) : 41201 - 41209
  • [18] Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors
    Medina, Jesus R.
    Becker, Christopher J.
    Blackledge, Charles W.
    Duquenne, Celine
    Feng, Yanhong
    Grant, Seth W.
    Heerding, Dirk
    Li, William H.
    Miller, William H.
    Romeril, Stuart P.
    Scherzer, Daryl
    Shu, Arthur
    Bobko, Mark A.
    Chadderton, Antony R.
    Dumble, Melissa
    Gardiner, Christine M.
    Gilbert, Seth
    Liu, Qi
    Rabindran, Sridhar K.
    Sudakin, Valery
    Xiang, Hong
    Brady, Pat G.
    Campobasso, Nino
    Ward, Paris
    Axten, Jeffrey M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) : 1871 - 1895
  • [19] Discovery of Novel, Potent, and Selective Inhibitors of 3-Phosphoinositide-Dependent Kinase (PDK1)
    Murphy, Sean T.
    Alton, Gordon
    Bailey, Simon
    Baxi, Sangita M.
    Burke, Benjamin J.
    Chappie, Thomas A.
    Ermolieff, Jacques
    Ferre, RoseAnn
    Greasley, Samantha
    Hickey, Michael
    Humphrey, John
    Kablaoui, Natasha
    Kath, John
    Kazmirski, Steven
    Kraus, Michelle
    Kupchinsky, Stan
    Li, John
    Lingardo, Laura
    Marx, Matthew A.
    Richter, Dan
    Tanis, Steven P.
    Tran, Khanh
    Vernier, William
    Xie, Zhi
    Yin, Min-Jean
    Yu, Xiao-Hong
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (24) : 8490 - 8500
  • [20] 3-Cyclohexylindoles: A new class of inhibitors of 3-phosphoinositide-dependent kinase 1 (PDK1)
    Kutterer, Kristina M. K.
    Tang, Zhilian
    Aplasca, Alexis
    Malana, Anthony
    Guo, Bing
    Han, Xin
    Arndt, Kim
    Gopalsamy, Ariamala
    Ellingboe, John W.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 809 - 809